Annual report
9989.TEDINET S100OH6L
Period2021-04-01 → 2022-03-31
Filed2022-06-27
StandardJapan GAAP
ConsolidatedYes
Data checks22 of 24 passed
Key figures · 160
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥648.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥634.3bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥617.8bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥588.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥564.2bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥34.1bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥37.3bn | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥34.7bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥38.2bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥37.2bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥35.8bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥36.8bn | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥34.7bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥37.2bn | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥23.9bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥25.3bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥23.7bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥23.9bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥24.8bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥23.9bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥25.3bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥325.8bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥308.5bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥284.3bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥262.2bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥246.6bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥105.2bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥103.4bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥220.6bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥205.2bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥186.8bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥171.1bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥154.8bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥89.3bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥86.5bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥89.3bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥86.5bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥80.7bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥70.2bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥60.5bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥31.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥31.8bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥32.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥31.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥36.1bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥20.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥17.9bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥13.9bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥13.6bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥15.2bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥8.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥8.1bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥7.9bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥7.7bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6.4bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥204.02 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥216.68 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥202.67 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥204.76 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥212.31 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥204.01 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥216.63 | 2020-04-01 → 2021-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥202.67 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥204.76 | 2018-04-01 → 2019-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥212.31 | 2017-04-01 → 2018-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥1,886.4 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,754.32 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,597.57 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,462.72 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,323.88 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 67.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.5% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.2% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.7% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 11.2% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.9% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.2% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.7% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.1% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 6,015 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 5,634 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 5,241 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 4,984 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 4,834 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥413.5bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥415.9bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥410.6bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥413.0bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥412.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥399.1bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥387.5bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥20.8bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥23.9bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥21.3bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥24.6bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥26.6bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥27.4bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥27.3bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥21.3bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥26.2bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥14.9bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥18.7bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥16.8bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥18.5bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥18.6bn | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥244.1bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥235.3bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥214.1bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥202.5bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥192.0bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥80.2bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥78.0bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥163.9bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥157.3bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥145.6bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥136.7bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥125.8bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥74.2bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥75.5bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥127.09 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥160.15 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥143.42 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥158.57 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥159.23 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥127.09 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥160.12 | 2020-04-01 → 2021-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥143.42 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥158.56 | 2018-04-01 → 2019-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥159.23 | 2017-04-01 → 2018-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥71 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥68 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥66 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,401.22 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,344.86 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,244.88 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,168.52 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,075.92 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 67.1% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.8% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.0% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.5% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.5% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 9.3% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.4% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.9% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.1% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.7% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 119,331,184 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 119,331,184 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 119,331,184 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 119,331,184 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 134,331,184 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 3,795 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 3,517 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 3,112 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 2,978 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 2,901 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 52
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥46.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥46.0bn |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | −¥30.5bn |
| Discount Storereportable segment | capex | 2021-04-01 → 2022-03-31 | ¥10.8bn |
| Discount Storereportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥4.5bn |
| Discount Storereportable segment | employees | at 2022-03-31 | 1611 pure |
| Discount Storereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥269.9bn |
| Discount Storereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥269.9bn |
| Discount Storereportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥12m |
| Discount Storereportable segment | segment assets | at 2022-03-31 | ¥106.6bn |
| Discount Storereportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥12.4bn |
| Drug Storereportable segment | capex | 2021-04-01 → 2022-03-31 | ¥11.5bn |
| Drug Storereportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥5.7bn |
| Drug Storereportable segment | employees | at 2022-03-31 | 4404 pure |
| Drug Storereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥424.8bn |
| Drug Storereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥378.9bn |
| Drug Storereportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥46.0bn |
| Drug Storereportable segment | segment assets | at 2022-03-31 | ¥249.6bn |
| Drug Storereportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥21.7bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥22.3bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥10.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥694.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥648.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥46.0bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥356.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥34.1bn |
| Reconciling Itemsreconciling | revenue | 2020-04-01 → 2021-03-31 | −¥43.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2020-04-01 → 2021-03-31 | −¥43.7bn |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | −¥22.7bn |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2021-03-31 | −¥10m |
| Discount Storereportable segment | capex | 2020-04-01 → 2021-03-31 | ¥9.5bn |
| Discount Storereportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥3.8bn |
| Discount Storereportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥255.7bn |
| Discount Storereportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥255.7bn |
| Discount Storereportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥14m |
| Discount Storereportable segment | segment assets | at 2021-03-31 | ¥90.7bn |
| Discount Storereportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥12.3bn |
| Drug Storereportable segment | capex | 2020-04-01 → 2021-03-31 | ¥9.1bn |
| Drug Storereportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥4.8bn |
| Drug Storereportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥422.3bn |
| Drug Storereportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥378.6bn |
| Drug Storereportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥43.6bn |
| Drug Storereportable segment | segment assets | at 2021-03-31 | ¥240.5bn |
| Drug Storereportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥25.0bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-04-01 → 2021-03-31 | ¥18.6bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-04-01 → 2021-03-31 | ¥8.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥678.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥634.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥43.7bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥331.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥37.4bn |
| Drug Storereportable segment | employees | at 2022-03-31 | 3795 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,569
| Item | Context | Value | Unit |
|---|---|---|---|
| Income taxes paid ope cf | CurrentYearDuration | -13083000000 | JPY |
| Proceeds from subsidy ope cf | Prior1YearDuration | 73000000 | JPY |
| Proceeds from subsidy ope cf | CurrentYearDuration | 114000000 | JPY |
| Net cash provided by used in operating activities | Prior1YearDuration | 31761000000 | JPY |
| Net cash provided by used in operating activities | CurrentYearDuration | 31682000000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YearDuration | -15817000000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYearDuration | -18825000000 | JPY |
| Purchase of intangible assets inv cf | Prior1YearDuration | -658000000 | JPY |
| Purchase of intangible assets inv cf | CurrentYearDuration | -964000000 | JPY |
| Payments of loans receivable inv cf | Prior1YearDuration | -844000000 | JPY |
| Payments of loans receivable inv cf | CurrentYearDuration | -1248000000 | JPY |
| Collection of loans receivable inv cf | Prior1YearDuration | 62000000 | JPY |
| Collection of loans receivable inv cf | CurrentYearDuration | 60000000 | JPY |
| Payments for lease and guarantee deposits inv cf | Prior1YearDuration | -1456000000 | JPY |
| Payments for lease and guarantee deposits inv cf | CurrentYearDuration | -1177000000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | Prior1YearDuration | 605000000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | CurrentYearDuration | 803000000 | JPY |
| Other net inv cf | Prior1YearDuration | 207000000 | JPY |
| Other net inv cf | CurrentYearDuration | 694000000 | JPY |
| Net cash provided by used in investment activities | Prior1YearDuration | -17901000000 | JPY |
| Net cash provided by used in investment activities | CurrentYearDuration | -20659000000 | JPY |
| Cash dividends paid fin cf | Prior1YearDuration | -8064000000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration | -8187000000 | JPY |
| Purchase of treasury stock fin cf | Prior1YearDuration | － | JPY |
| Purchase of treasury stock fin cf | CurrentYearDuration | -0 | JPY |
| Proceeds from exercise of stock option fin cf | Prior1YearDuration | － | JPY |
| Proceeds from exercise of stock option fin cf | CurrentYearDuration | 0 | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration | -8064000000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | -8187000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | 5795000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | 2835000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 80699000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 86495000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 86495000000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 89330000000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 4 | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method | CurrentYearInstant | － | |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E03226-000DrugStoreReportableSegmentsMember | 378611000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E03226-000DiscountStoreReportableSegmentsMember | 255699000000 | JPY |
| Revenues from external customers | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 634310000000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YearDuration | 634310000000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E03226-000DrugStoreReportableSegmentsMember | 43640000000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E03226-000DiscountStoreReportableSegmentsMember | 14000000 | JPY |
| Transactions with other segments | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 43655000000 | JPY |
| Transactions with other segments | Prior1YearDuration_ReconcilingItemsMember | -43655000000 | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E03226-000DrugStoreReportableSegmentsMember | 422251000000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E03226-000DiscountStoreReportableSegmentsMember | 255714000000 | JPY |
| Net sales | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 677966000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 22 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | mismatch |
| statement vs summary · revenue | mismatch |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |